Inhibiting TREM-1 with synthetic peptides like LP17 has been shown to reduce neuronal damage, enhance hippocampal synaptic plasticity, decrease infarct size, reduce BBB leakage, and improve functional recovery in ischemic stroke models. The gene discussed is TREM1; the disease is ischemic stroke.